JP Morgan Chase
WX

JP Morgan Chase’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

JP Morgan Chase’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,342
Closed -$447K – 4946
2015
Q3 		$447K Sell
10,342
-189,050
-95% -$7.98M ﹤0.01% 3455
2015
Q2 		$8.43M Buy
199,392
+122,646
+160% +$5.17M ﹤0.01% 2046
2015
Q1 		$2.98M Buy
76,746
+22,449
+41% +$865K ﹤0.01% 2659
2014
Q4 		$1.83M Sell
54,297
-138,305
-72% -$4.88M ﹤0.01% 3018
2014
Q3 		$6.74M Sell
192,602
-801,614
-81% -$27.5M ﹤0.01% 2175
2014
Q2 		$32.7M Buy
994,216
+7,458
+0.8% +$255K 0.01% 1068
2014
Q1 		$36.4M Sell
986,758
-520,504
-35% -$19.1M 0.01% 987
2013
Q4 		$57.8M Sell
1,507,262
-1,134,219
-43% -$35.8M 0.02% 738
2013
Q3 		$72.4M Sell
2,641,481
-275,242
-9% -$6.52M 0.02% 651
2013
Q2 		$61.3M Buy
+2,916,723
New +$56.9M 0.02% 680

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

JP Morgan Chase's WX Position: Q4 2015 in Review

JP Morgan Chase sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,342 shares — an estimated $447K sold.

JP Morgan Chase first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $72.4M in Q3 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • JP Morgan Chase reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • JP Morgan Chase sold 10,342 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $447K.
  • JP Morgan Chase first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • JP Morgan Chase's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $72.4M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on JP Morgan Chase's 13F filing for Q4 2015, filed 12 Feb 2016.